Showing results (171-180 of 250) with videos related to

Sort By:
Pageof 25
The Journal of Experimental Medicine|February 1, 1979
Immunodeterminant specificity of human immunity to type III group B streptococcusD L Kasper, C J Baker, R S Baltimore, et al.
Infection and Immunity|June 1, 1982
Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combinationR L Penn, E B Lewin, R G Douglas, et al.
Reviews of Infectious Diseases|March 1, 1981
Response to pneumococcal vaccine among children with Hodgkin's diseaseS S Donaldson, K L Vosti, F R Berberich, et al.
Transfusion|October 1, 1996
Human immunodeficiency virus type 1 activation after blood transfusionP M Mudido, D Georges, D Dorazio, et al.
Blood|July 4, 2001
Survival of transfused donor white blood cells in HIV-infected recipientsM S Kruskall, T H Lee, S F Assmann, et al.
Clinical and Diagnostic Laboratory Immunology|July 17, 1998
Measurement of induced cytokines in AIDS clinical trials using whole blood: a preliminary report. ACTG Inducible Cytokines Focus Group. AIDS Clinical Trials GroupR S Wallis, H M Lederman, J Spritzler, et al.
The Journal of Trauma|September 1, 1983
Response of traumatized splenectomized patients to immediate vaccination with polyvalent pneumococcal vaccineE S Caplan, H Boltansky, M J Snyder, et al.
Infection and Immunity|July 1, 1984
Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidisG R Siber, D M Ambrosino, J McIver, et al.
Infection and Immunity|March 18, 2000
Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in miceD Pavliakova, J S Moncrief, D M Lyerly, et al.
Lancet (London, England)|January 28, 1978
Immune response after splenectomyJ L Sullivan, H D Ochs, G Schiffman, et al.
Pageof 25